Objective 5 of the NZ Antimicrobial Resistance Action Plan is to establish and support clear governance, collaboration and investment arrangements for a sustainable approach to countering antimicrobial resistance.
Establish a sustainable national governance structure to coordinate all efforts to minimise antimicrobial resistance.
|5.||Review the effectiveness of the governance arrangements in line with Priority action area 16, activity 4 and revise them as necessary.|
|6.||Review the role and effectiveness of the Health and Primary Industry AMR coordination groups, in line with Priority action area 16, activities 1 and 2, in exchanging information and providing advice and updated information on AMR activities, and revise as necessary.|
Ensure that there is sustainable investment in initiatives to minimise the impacts of antimicrobial resistance. This includes ongoing investment in surveillance, communication, stewardship and infection prevention and control.
|1.||Explore and use any funding opportunities in the public and private sectors to minimise the impact of antimicrobial resistance, including through communication, surveillance, stewardship and infection prevention and control across human health, animal health and agriculture.|
|2.||Develop the business cases required to support implementation of all five objectives of the New Zealand AMR Action Plan, including communication, surveillance, stewardship, infection prevention and control and governance across human health, animal health and agriculture.|
Establish the necessary national and international links and collaborations to implement the AMR Action Plan effectively.
|3.||Based on opportunities identified in Priority action area 18, activities 1 and 2, plan and implement strategic collaborations and engagement with other governments and international partners on antimicrobial resistance across human health, animal health and agricultural sectors.|
|4.||Establish closer ties with other countries to promote the quality, safety and efficacy of antimicrobials; for example, by strengthening veterinary medicine supply chains.|